BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs2300478, IGF1, Coagulation, Arthritis, Liver, Metabolism of nitric oxide, Doxycycline)
Bookmark Forward

QuickView for hydroxamic acids (compound)


Genetic Markers

Most Correlated Genes

  1. DHRS2
  2. CRIP1
  3. SERPINI1
  4. TXNIP
  5. AGR2
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. heterocyclic compound binding
  2. organic cyclic compound binding
  3. organic cyclic compound metabolic process
  4. heterocycle metabolic process
  5. regulation of nitrogen compound metabolic process
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Iron chelation in regulation of gene expression in DMS-53 small cell lung carcinoma cells
  2. Embryonic and trophoblast stem cells treated with Trichostatin A
  3. Pancreatic cell lines treated with chromatin-targeting small molecules
  4. Neurospheres cultured from embryonic striatum and treated with BMP2 or trichostatin A
  5. Pre-cursor B cell acute lymphoblastic leukemia cells and patient samples treated with vorinostat
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Photoinduced DNA cleavage by anthracene based hydroxamic acids.
  2. Copper extraction by fatty hydroxamic acids derivatives synthesized based on palm kernel oil.
  3. The use of hydroxamic acids and sodium nitrate to enhance the antitumor effect of cyclophosphamide].
  4. Hydroxamic acids as matrix metalloproteinase inhibitors.
  5. Synthesis and antitumor activity of novel diaryl ether hydroxamic acids derivatives as potential HDA…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors
  2. Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer
  3. Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Loca…
  4. Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
  5. Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Sma…
Explore Clinical Trials Results
  • Copyright © 2023 Illumina Inc. All rights reserved.